Standard BioTools Inc.
LAB
$1.29
-$0.04-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.62% | -56.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.62% | -56.71% | |||
| Cost of Revenue | 21.38% | -63.03% | |||
| Gross Profit | -3.81% | -49.56% | |||
| SG&A Expenses | -5.76% | -20.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.30% | -41.88% | |||
| Operating Income | 2.13% | 18.57% | |||
| Income Before Tax | 22.17% | 30.51% | |||
| Income Tax Expenses | -411.76% | -143.75% | |||
| Earnings from Continuing Operations | 24.38% | 31.41% | |||
| Earnings from Discontinued Operations | -492.79% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.53% | 23.59% | |||
| EBIT | 2.13% | 18.57% | |||
| EBITDA | 1.69% | 22.26% | |||
| EPS Basic | -27.76% | 24.40% | |||
| Normalized Basic EPS | 33.08% | 22.22% | |||
| EPS Diluted | -27.76% | 24.40% | |||
| Normalized Diluted EPS | 33.08% | 22.22% | |||
| Average Basic Shares Outstanding | 0.60% | 0.99% | |||
| Average Diluted Shares Outstanding | 0.60% | 0.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||